From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations
Transl Lung Cancer Res
.
2020 Apr;9(2):180-183.
doi: 10.21037/tlcr.2020.03.07.
Authors
María José Serrano
1
2
3
,
José Exposito-Hernández
2
,
Rosa Guerrero
2
,
Javier Lopez-Hidalgo
4
,
Mariano Aguilar
3
,
Jose A Lorente
1
5
,
Enrique de Álava
6
7
,
M Carmen Garrido-Navas
1
Affiliations
1
GENYO, Centre for Genomics and Oncological Research (Pfizer/University of Granada/Andalusian Regional Government), PTS Granada, Granada, Spain.
2
Integral Oncology Division, Virgen de las Nieves University Hospital, Granada, Spain.
3
Department of Pathological Anatomy, Faculty of Medicine, Campus de Ciencias de la Salud, University of Granada, Granada, Spain.
4
Pathological Anatomy Unit, San Cecilio University Hospital, Granada, Spain.
5
Laboratory of Genetic Identification, Department of Legal Medicine, University of Granada, Granada, Spain.
6
Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain.
7
Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain.
PMID:
32420057
PMCID:
PMC7225138
DOI:
10.21037/tlcr.2020.03.07
No abstract available
Publication types
Editorial
Comment